Gilead Sciences, Inc. 8-K Report: Key Developments Unveiled on April 24, 2025
Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: Gilead Sciences, Inc.
- State of Incorporation: Delaware (DE)
- CIK (Central Index Key): 0000882095
- IRS Employer Identification Number: 94-3047598
- Address: 333 Lakeside Drive, Foster City, CA 94404
- Phone Number: 650-574-3000
- Filing Details:
- Form Type: 8-K (a current report used to disclose important events that shareholders should know about)
- Filing Date: April 24, 2025
- Security Information:
- Type of Security: Common Stock
- Par Value: $0.001 per share
- Stock Symbol: GILD
- Exchange: NASDAQ
- Reporting Period:
- Start Date: April 24, 2025
- End Date: April 24, 2025
Insights:
- The filing is a current report (8-K) indicating that Gilead Sciences, Inc. has likely disclosed significant information or an event that could impact the company or its shareholders on the date of filing.
- The report pertains specifically to the common stock of Gilead, suggesting potential developments related to equity financing, shareholder meetings, mergers/acquisitions, or other significant corporate actions.
This information is critical for investors, analysts, and stakeholders who are tracking Gilead's activities and performance on the market.